{"id":476087,"date":"2021-04-14T08:03:56","date_gmt":"2021-04-14T12:03:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/"},"modified":"2021-04-14T08:03:56","modified_gmt":"2021-04-14T12:03:56","slug":"inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/","title":{"rendered":"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">IRVINE, Calif., April  14, 2021  (GLOBE NEWSWIRE) &#8212; Inari Medical, Inc. (NASDAQ: NARI) (\u201cInari\u201d), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced a new global partnership with Aidoc, the leading provider of enterprise artificial intelligence (\u201cAI\u201d) solutions, to accelerate the adoption and the clinical impact of AI to advance the timely detection and treatment of pulmonary embolism (\u201cPE\u201d).<\/p>\n<p align=\"justify\">\u201cThe partnership between Inari and Aidoc is a natural fit,\u201d said Dr. Jonathan Paul, Associate Professor of Medicine and Director of the PE program at the University of Chicago Medical Center. \u201cFlowTriever has become a frontline treatment option for intermediate and high-risk PE at our institution. We were proud to pilot and help refine the Aidoc PE suite and have integrated the commercial version of the software into our workflow. We have been pleased to see the impact Aidoc has had on quickly flagging studies with suspected PE findings and improving our patient outcomes.\u201d<\/p>\n<p align=\"justify\">\u201cWe are the first company to offer an AI-based activation solution that facilitates rapid triage of patient scans with suspected positive findings for PE. Our Care Coordination suite includes Aidoc\u2019s FDA-cleared solution for triage and notification of suspected PE together with Imbio\u2019s FDA-cleared automated RV\/LV analysis. The care team involved in the reading workflow can now harness our mobile app at their fingertips to synchronize on the patient treatment path, with access to real-time image, data, video and chat features,\u201d said Elad Walach, co-founder and CEO of Aidoc. \u201cWe are extremely excited to be partnering with Inari and see the potential of this partnership to shift the standard of care in PE patient triage and treatment to advance a field that is ripe for innovation.\u201d<\/p>\n<p align=\"justify\">\u201cWe are committed to helping hospitals develop best-in-class clinical pathways to identify, triage, and treat patients with venous thromboembolism. Recent data has shown that in even the most sophisticated academic programs with established PE Response Teams (\u201cPERT\u201d), as many as three quarters of intermediate-high risk PE patients are still slipping through the cracks and not benefiting from a PERT activation,\u201d said Bill Hoffman, Inari\u2019s Chief Executive Officer. \u201cWe believe that artificial intelligence offers a promising new tool to prevent this from happening, and to ensure that all intermediate-high risk PE patients are identified and assessed for optimal treatment as quickly as possible.\u201d<\/p>\n<p align=\"justify\">Dr. Thomas Tu, Inari\u2019s Chief Medical Officer, will be hosting a special live Clot Warrior Academy episode on Wednesday, April 21<sup>st<\/sup>, at 4pm ET featuring special guests Dr. Hamid Mojibian, Dr. Jonathan Paul, and Dr. Robert Lookstein entitled, <em>Using AI to Optimize PE Patient Triage: The Aidoc Experience<\/em>. Register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0e2Qlj6Kw9-rMDV_MU4fIBny7fzhMgyDBQWZ79iasbjwIYQiSZXIwVbqRK-PH_RLZzI5OuYNyxzoFM9s4PXR6SN-naSdA48AISFH79ukIQQ=\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Inari Medical, Inc.<\/strong><br \/>\n        <br \/>Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.<\/p>\n<p align=\"justify\">\n        <strong>About Aidoc<\/strong><br \/>\n        <br \/>Aidoc is the leading provider of artificial intelligence solutions that support physician workflows by helping them expedite patient treatment and improve quality of care. The company\u2019s AI solutions reduce turnaround time and increase quality and efficiency by flagging acute anomalies in real time. These acute anomalies include (but are not limited to) ICH, LVO, PE, C-spine fractures, incidental PE and intraabdominal free air \u2013 all of which are commercially in use and FDA cleared. The company offers the broadest integration into the clinical workflow, providing care collaboration tools for radiology as well as multidisciplinary teams including Stroke and PE response teams. Aidoc\u2019s \u201cAlways-on\u201d AI acts as a safety net running behind the scenes and can cut the time from scan to diagnosis for some patients from hours to under five minutes, speeding up treatment and improving prognosis. Aidoc\u2019s solutions are currently deployed at over 500 leading medical centers in the U.S. and worldwide. Connect with us at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=69EQWtkJQc1fnDxI-vj9u0LJQ_Zf3j0ALRysMQYEELUwnRsWfEwjHxAQfsZNS6U1d79V79-I2p0ae8ubqbyMwQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>@aidocmed<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contacts:<\/strong><br \/>\n        <br \/>Westwicke Partners<br \/>Caroline Corner<br \/>Phone +1-415-202-5678 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sCFbs8oVjNXAdcaz7yK2m3990jMqfujZ3ay4Ps5gPo1U6Dx5HpK6YWcptdH632KYUw92SynUaGKs11coQXl4zI2OXVWzDegpZke5ZmH31pwB3v2-6pP1f0-BmYD3bVfk\" rel=\"nofollow noopener\" target=\"_blank\"><u>caroline.corner@westwicke.com<\/u><\/a><\/p>\n<p align=\"justify\">Aidoc Medical<br \/>Ariella Shoham<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mLJ9C_Ru7AZu6xdiUf-OR9CJT7FYmdJ-0ei3ytc2EbLRN70tvDJC_kb_GFRbx248v9_GJz1qcfm7Om35HSwYuQ==\" rel=\"nofollow noopener\" target=\"_blank\">ariella@aidoc.com<\/a><\/u><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/fff753db-1cbb-4d7b-8779-34eb61e54de9\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., April 14, 2021 (GLOBE NEWSWIRE) &#8212; Inari Medical, Inc. (NASDAQ: NARI) (\u201cInari\u201d), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced a new global partnership with Aidoc, the leading provider of enterprise artificial intelligence (\u201cAI\u201d) solutions, to accelerate the adoption and the clinical impact of AI to advance the timely detection and treatment of pulmonary embolism (\u201cPE\u201d). \u201cThe partnership between Inari and Aidoc is a natural fit,\u201d said Dr. Jonathan Paul, Associate Professor of Medicine and Director of the PE program at the University of Chicago Medical Center. \u201cFlowTriever has become a frontline treatment option for intermediate and high-risk PE at our institution. We &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-476087","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., April 14, 2021 (GLOBE NEWSWIRE) &#8212; Inari Medical, Inc. (NASDAQ: NARI) (\u201cInari\u201d), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced a new global partnership with Aidoc, the leading provider of enterprise artificial intelligence (\u201cAI\u201d) solutions, to accelerate the adoption and the clinical impact of AI to advance the timely detection and treatment of pulmonary embolism (\u201cPE\u201d). \u201cThe partnership between Inari and Aidoc is a natural fit,\u201d said Dr. Jonathan Paul, Associate Professor of Medicine and Director of the PE program at the University of Chicago Medical Center. \u201cFlowTriever has become a frontline treatment option for intermediate and high-risk PE at our institution. We &hellip; Continue reading &quot;Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-14T12:03:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism\",\"datePublished\":\"2021-04-14T12:03:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/\"},\"wordCount\":779,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/\",\"name\":\"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=\",\"datePublished\":\"2021-04-14T12:03:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/","og_locale":"en_US","og_type":"article","og_title":"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism - Market Newsdesk","og_description":"IRVINE, Calif., April 14, 2021 (GLOBE NEWSWIRE) &#8212; Inari Medical, Inc. (NASDAQ: NARI) (\u201cInari\u201d), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced a new global partnership with Aidoc, the leading provider of enterprise artificial intelligence (\u201cAI\u201d) solutions, to accelerate the adoption and the clinical impact of AI to advance the timely detection and treatment of pulmonary embolism (\u201cPE\u201d). \u201cThe partnership between Inari and Aidoc is a natural fit,\u201d said Dr. Jonathan Paul, Associate Professor of Medicine and Director of the PE program at the University of Chicago Medical Center. \u201cFlowTriever has become a frontline treatment option for intermediate and high-risk PE at our institution. We &hellip; Continue reading \"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-14T12:03:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism","datePublished":"2021-04-14T12:03:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/"},"wordCount":779,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/","name":"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=","datePublished":"2021-04-14T12:03:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjY4OCM0MTIwMTY0IzIxOTQ1MTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inari-medical-announces-global-partnership-with-aidoc-to-advance-the-timely-detection-and-treatment-of-pulmonary-embolism\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Inari Medical Announces Global Partnership with Aidoc to Advance the Timely Detection and Treatment of Pulmonary Embolism"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=476087"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476087\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=476087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=476087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=476087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}